PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that Arthur Bedrosian, the company’s president and CEO, purchased 20,467 shares of Lannett Company common stock in the open market on September 9, 2011. A Form 4 was filed today reflecting the purchase of the shares.
